New pill could ease arthritis pain for those Who've tried everything
NCT ID NCT06276998
First seen Jan 16, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study tests an experimental oral drug called LNK01001 (Zemprocitinib) in adults with moderate-to-severe rheumatoid arthritis who have not responded well to biologic treatments. About 430 participants will receive either the drug or a placebo for 24 weeks, followed by a longer safety period. The goal is to see if the drug reduces joint pain and swelling better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Medical College Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.